Tumour angiogenesis, vascular biology and enhanced drug delivery

Journal of Drug Targeting

Volumn 12, Issue 5, 2004, Pages 245-255

  Dass, Crispin ^a  

^a GeneType   (Australia)

Author keywords

Angiogenesis; Cancer; Drug; Tumour; Vasculature

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANGIOTENSIN; ANGIOZYME; ANTINEOPLASTIC AGENT; APHIDICOLIN; BEVACIZUMAB; CADHERIN; COLLAGENASE; CYCLOPHOSPHAMIDE; DEOXYRIBOZYME; DOXORUBICIN; EARLY GROWTH RESPONSE FACTOR 1; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; HYALURONIDASE; LIPOSOME; MONOCLONAL ANTIBODY; NANOPARTICLE; OLIGONUCLEOTIDE; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER RESEARCH; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; DRUG SELECTIVITY; DRUG TARGETING; DRUG TRANSPORT; ENCAPSULATION; FIBROSARCOMA; GENE THERAPY; GENE TRANSFER; HUMAN; KIDNEY CANCER; LEWIS CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA B16; METASTASIS POTENTIAL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PANCREAS CANCER; PHASE TRANSITION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; RELIABILITY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 4644269745     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860410001713163     Document Type: Article

References (125)

1. Akhtar, S., Hughes, M.D., Khan, A., Bibby, M., Hussain, M., Nawaz, Q., Double, J. and Sayyed, P. (2000) "The delivery of antisense therapeutics", Adv. Drug Deliv. Rev. 44, 3-21.
2. Anwer, K., Meaney, C., Kao, G., Hussain, N., Shelvin, R., Earls, R.M., Leonard, P., Quezada, A., Rolland, A.P. and Sullivan, S.M. (2000a) "Cationic lipid-based delivery system for systemic cancer gene therapy", Cancer Gene Ther. 7, 1156-1164.
3. Anwer, K., Bailey, A. and Sullivan, S.M. (2000b) "Targeted gene delivery: A two-pronged approach", Crit. Rev. Ther. Drug Carrier. Syst. 17, 377-424.
4. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M. and Isner, J.M. (1999) "VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells", EMBO J. 18, 3964-3972.
5. Baxter, L.T. and Jain, R.K. (1990) "Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics", Microvasc. Res. 40, 246-263.
6. Beckenlehner, K., Bannke, S., Spruss, T., Bernhardt, G., Schonenberg, H. and Schiess, W. (1992) "Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo" , J. Cancer Res. Clin. Oncol. 118, 591-596.
7. Benjamin, L.E. and Keshet, E. (1997) "Conditonal switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal", Proc. Natl Acad. Sci. USA 94, 8761-8766.
8. Boucher, Y., Leunig, M. and Jain, R.K. (1996) "Tumor angiogenesis and interstitial hypertension", Cancer Res. 56, 4264-4266.
9. Brekken, R.A., Huang, X., King, S.W. and Thorpe, P.E. (1998) "Vascular endothelial growth factor as a marker of tumor endothelium", Cancer Res. 58(9), 1952-1959, May 1.
10. 2+ and von Willebrand factor release in human endothelial cells", Am. J. Pathol. 138, 213-221.
11. Browder, T., Butterfield, C.E., Kraling, B.M., Shi, B., Marshall, B., O'Reilly, M.S. and Folkman, J. (2000) "Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer", Cancer Res. 60, 1878-1886.
12. Burrows, F.J. and Thorpe, P.E. (1993) "Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature", Proc. Natl Acad. Sci. USA 90, 8996-9000.
13. Burton, M.A., Gray, B.N. and Coletti, A. (1988) "Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma", Eur. J. Cancer Clin. Oncol. 24, 1373-1376.
14. Calabretta, B., Sims, R.B., Valtieri, M., Caracciolo, D., Szczylik, C., Venturelli, D., Ratajczak, M., Beran, M. and Gerwitz, A.M. (1991) "Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vivo study relevant to bone marrow purging", Proc. Natl Acad. Sci. USA 88, 2351-2357.
15. Campbell, R.B., Fukumura, D., Brown, E.B., Mazzola, L.M., Izumi, Y., Jain, R.K., Torchilin, V.P. and Munn, L.L. (2002) " Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors", Cancer Res. 62, 6831-6936.
16. Chen, Q.R., Kumar, D., Stass, S.A. and Mixson, A.J. (1999) "Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice", Cancer Res. 59, 3308-3312.
17. Clarijs, R., Schalkwijk, L., Ruiter, D.J. and de Waal, R.M. (2001) "Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma", Investig. Ophthalmol. Vis. Sci. 42, 1422-1428.
18. Dass, C.R. (2002) "Vehicles for oligonucleotide delivery to tumours", J. Pharm. Pharmacol. 54, 3-27.
19. Dass, C.R. and Burton, M.A. (2002) "A model for evaluating selective delivery of plasmid DNA to tumours via the vasculature", Cancer Biother. Radiopharm. 17, 501-505.
20. Dass, C.R. and Burton, M.A. (2003) "Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in vivo", J. Pharm. Pharmacol. 55, 19-25.
21. Dass, C.R. and Su, T. (2000) "Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells", J. Pharm. Pharmacol. 51, 1301-1317.
22. Dellian, M., Yuan, F., Trubetskoy, V.S., Torchilin, V.P. and Jain, R.K. (2000) "Vascular permeability in a human tumour xenograft: molecular charge dependence", Br. J. Cancer 82, 1513-1518.
23. Detmar, M., Brown, L.F., Schon, M.P., Elicker, B.M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K.P. and Jain, R.K. (1998) "Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice", J. Investig. Dermatol. 111, 1-6.
24. Dudar, T.E. and Jain, R.K. (1983) "Microcirculatory flow changes during tissue growth", Microvasc. Res. 25, 1-21.
25. Dvorak, H.F. (1986) "Tumors: Wounds that do not heal. Similarities between tumor stroma. generation and wound healing", N. Engl. J. Med. 315, 1650-1659.
26. 311P NMR", Proc. Natl Acad. Sci. USA 90, 2646-2650.
27. Fahmy, R.G., Dass, C.R., Sun, L.Q., Chesterman, C.N. and Khachigian, L.M. (2003) "Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth", Nat. Med. 9, 1026-1032.
28. Ferrara, N. and Davis-Smyth, T. (1997) "The biology of vascular endothelial growth factor", Endocr. Rev. 18, 4-25.
29. Fidler, I.J. (2001) "Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment", J. Natl Cancer Inst. 93, 1040-1041.
30. Folkman, J. (1971) "Tumor angiogenesis: therapeutic implications", N. Engl. J. Med. 285, 1182-1186.
31. Folkman, J. (1986) "How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture", Cancer Res. 46, 467-473.
32. Folkman, J. (1992) "The role of angiogenesis in tumor growth", Semin. Cancer Biol. 3, 65-71.
33. Folkman, J. (1995) "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nat. Med. 1, 27-31.
34. Folkman, J. and Cotran, R. (1976) "Relation of vascular proliferation to tumor growth", Int. Rev. Exp. Pathol. 16, 207-248.
35. Folkman, J. and Klagsburn, M. (1987) "Angiogenic factors", Science 235, 442-447.
36. Fukumura, D., Yuan, F., Monsky, W.L., Chen, Y. and Jain, R.K. (1997a) "Effect of host microenvironment on the microcirculation of human colon adenocarcinoma", Am. J. Pathol. 151, 679-688.
37. Fukumura, D., Yuan, F., Endo, M. and Jain, R.K. (1997b) "Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions", Am. J. Pathol. 150, 713-725.
38. Gimbrone, M.A., Jr., Cotran, R.S., Leapman, S.B. and Folkman, J. (1974) "Tumor growth and neovascularization: an experimental model using the rabbit cornea", J. Natl Cancer Inst. 52, 413-427.
39. Goldman, C.K., Kendall, R.L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G.Y., Siegal, G.P., Mao, X., Bett, A.J., Huckle, W.R., Thomas, K.A. and Curiel, D.T. (1998) "Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate", Proc. Natl Acad. Sci. USA 95, 8795-8800.
40. Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C.J., Zuelke, C., Farkas, S., Anthuber, M., Jauch, K.W. and Geissler, E.K. (2002) "Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor", Nat. Med. 8, 128-135.
41. Hanahan, D. and Folkman, J. (1996) "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis", Cell 86, 353-364.
42. Hashizume, H., Baluk, P., Morikawa, S., McLean, J.W., Thurston, G., Roberge, S., Jain, R.K. and McDonald, D.M. (2000) "Openings between defective endothelial cells explain tumor vessel leakiness", Am. J. Pathol. 156, 1363-1380.
43. He, Y., Karpanen, T. and Alitalo, K. (2004) "Role of lymphangiogenic factors in tumor metastasis", Biochim. Biophys. Acta 1654, 3-12.
44. Hobarth, K., Maier, U. and Marberger, M. (1992) "Topical chemoprophylaxis of superficial bladder cancer with mitomycin C and adjuvant hyaluronidase", Eur. Urol. 21, 206-210.
45. Hobbs, S.K., Monsky, W.L., Yuan, F., Roberts, W.G., Griffith, L., Torchilin, V.P. and Jain, R.K. (1998) "Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment", Proc. Natl Acad. Sci. USA 95, 4607-4612.
46. Holash, J., Maisonpierre, P.C., Compton, D., Boland, P., Alexander, C.R., Zagzag, D., Yancopoulos, G.D. and Wiegand, S.J. (1999) "Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF", Science 284, 1994-1998.
47. Hood, J.D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R.A., Xiang, R. and Cheresh, D.A. (2002) "Tumor regression by targeted gene delivery to the neovasculature", Science 296, 2404-2407.
48. Jain, R.K. (1989) "Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies", J. Natl Cancer Inst. 81, 570-576.
49. Jain, R.K. (2001) "Delivery of molecular and cellular medicine to solid tumors", Adv. Drug Deliv. Rev. 46, 149-168.
50. Jain, R.K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F. and Keshet, E. (1998) "Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor", Proc. Natl Acad. Sci. USA 95, 10820-10825.
51. Johnston, S.R. and Gore, M.E. (2001) "Caelyx: Phase II studies in ovarian cancer", Eur. J. Cancer 37, S8-S14.
52. Juliano, R.L. (1993) "The role of β1 integrins in tumors", Semin. Cancer Biol. 4, 277-283.
53. Kalebic, T., Garbisa, S., Glaser, B. and Liotta, L.A. (1983) "Basement membrane collagen: degradation by migrating endothelial cells", Science 221, 281-283.
54. Kerbel, R.S. (1997) "A cancer therapy resistant to resistance", Nature 390, 335-336.
55. Kim, S., Bell, K., Mousa, S.A. and Varner, J.A. (2000) "Regulation of angiogenesis in vivo by ligation of integrin α 5β1 with the central cell-binding domain of fibronectin", Am. J. Pathol. 156, 1345-1362.
56. Kisker, O., Becker, C.M., Prox, D., Fannon, M., D'Amato, R., Flynn, E., Fogler, W.E., Sim, B.K., Allred, E.N., Pirie-Shepherd, S.R. and Folkman, J. (2001) "Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model", Cancer Res. 61, 7669-7674.
57. Klimuk, S.K., Semple, S.C., Nahirney, P.N., Mullen, M.C., Bennett, C.F., Scherrer, P. and Hope, M.J. (2000) "Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity", J. Pharmacol. Exp. Ther. 292, 480-488.
58. Kong, H.L., Hecht, D., Song, W., Kovesdi, I., Hackett, N.R., Yayon, A. and Crystal, R.G. (1998) "Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor", Hum. Gene Ther. 9, 823-833.
59. Kong, G., Braun, R.D. and Dewhirst, M.W. (2000) "Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size", Cancer Res. 60, 4440-4445.
60. Kong, G., Braun, R.D. and Dewhirst, M.W. (2001) "Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature", Cancer Res. 61, 3027-3032.
61. Koukourakis, M.I., Koukouraki, S., Fezoulidis, I., Kelekis, N., Kyrias, G., Archimandritis, S. and Karkavitsas, N. (2000) "High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours", Br. J. Cancer 83, 1281-1286.
62. Kremer, C., Breier, G., Risau, W. and Plate, K.H. (1997) "Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system", Cancer Res. 57, 3852-3859.
63. Kristensen, C.A., Roberge, S. and Jain, R.K. (1997) "Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts", Clin. Cancer Res. 3, 319-324.
64. Kristjansen, P.E., Roberge, S., Lee, I. and Jain, R.K. (1994) "Tissue-isolated human tumor xenografts in athymic nude mice", Microvasc. Res. 48, 389-402.
65. Kristjansen, P.E., Brown, T.J., Shipley, L.A. and Jain, R.K. (1996) "Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer", Clin. Cancer Res. 2, 359-367.
66. Krol, A., Maresca, J., Dewhirst, M.W. and Yuan, F. (1999) "Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: Implications for drug delivery", Cancer Res. 59, 4136-4141.
67. Kumar, R., Kuniyasu, H., Bucana, C.D., Wilson, M.R. and Fidler, I.J. (1998) "Spatial and temporal expression of angiogenic molecules during tumor growth and progression", Oncol. Res. 10, 301-311.
68. Kunstfeld, R., Wickenhauser, G., Michaelis, U., Teifel, M., Umek, W., Naujoks, K., Wolff, K. and Petzelbauer, P. (2003) " Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model", J. Investig. Dermatol. 120, 476-482.
69. Leonetti, C., Biroccio, A., Benassi, B., Stringaro, A., Stoppacciaro, A., Semple, S.C. and Zupi, G. (2001) "Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line", Cancer Gene Ther. 8, 459-468.
70. Less, J.R., Posner, M.C., Skalak, T.C., Wolmark, N. and Jain, R.K. (1997) "Geometric resistance and microvascular network architecture of human colorectal carcinoma", Microcirculation 4, 25-33.
71. Leunig, M., Yuan, F., Berk, D.A., Gerweck, L.E. and Jain, R.K. (1994) "Angiogenesis and growth of isografted bone: Quantitative in vivo assay in nude mice", Lab. Investig. 71, 300-307.
72. Liao, F., Li, Y., O'Connor, W., Zanetta, L., Bassi, R., Santiago, A., Overholser, J., Hooper, A., Mignatti, P., Dejana, E., Hicklin, D.J. and Bohlen, P. (2000) "Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis", Cancer Res. 60, 6805-6810.
73. Lichtenbeld, H.C., Yuan, F, Michel, C.C. and Jain, R.K. (1996) "Perfusion of single tumor microvessels: Application to vascular permeability measurement", Microcirculation 3, 349-357.
74. Liotta, L.A. and Rao, C.N. (1985) "Role of the extracellular matrix in cancer", Ann. N. Y. Acad. Sci. 460, 333-344.
75. Liotta, L.A., Kleinerman, J. and Saidel, G.M. (1976) "The significance of heterogeneous tumor cell clumps in the metastatic process", Cancer Res. 36, 889-894.
76. Liu, F., Qi, H., Huang, L. and Liu, D. (1997) "Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration", Gene Ther. 4, 517-523.
77. Maeshima, Y., Colorado, P.C., Torre, A., Holthaus, K.A., Grunkemeyer, J.A., Ericksen, M.B., Hopfer, H., Xiao, Y, Stillman, I.E. and Kalluri, R. (2000) "Distinct antitumor properties of a type IV collagen domain derived from basement membrane", J. Biol. Chem. 275, 21340-21348.
78. Maeshima, Y., Yerramalla, U.L., Dhanabal, M., Holthaus, K.A., Barbashov, S., Kharbanda, S., Reimer, C., Manfredi, M., Dickerson, W.M. and Kalluri, R. (2001a) "Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis", J. Biol. Chem. 276, 31959-31968.
79. Maeshima, Y., Manfredi, M., Reimer, C., Holthaus, K.A., Hopfer, H., Chandamuri, B.R., Kharbanda, S. and Kalluri, R. (2001b) "Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin", J. Biol. Chem. 276, 15240-15248.
80. Michel, C.C. (1988) "Capillary permeability and how it may change", J. Physiol. 404, 1-29.
81. Mortimer, I., Tam, P., MacLachlan, I., Graham, R.W., Saravolac, E.G. and Joshi, P.B. (1999) "Cationic lipid-mediated transfection of cells in culture requires mitotic activity", Gene Ther. 6, 403-411.
82. Mui, B., Raney, S.G., Semple, S.C. and Hope, M.J. (2001) "Immune stimulation by a CpG-containing oligodeoxynucleotide in enhanced when encapsulated and delivered in lipid particles", J. Pharmacol. Exp. Ther. 298, 1185-1192.
83. Mukhopadhyay, D., Nagy, J.A., Manseau, E.J. and Dvorak, H.F. (1998) "Vascular permeability factor/vascular endothelial derived growth factor mediated signaling in mouse mesentary vascular endothelium", Cancer Res. 58, 1278-1284.
84. Murray, J.C. and Carmichael, J. (1995) "Targeting solid tumours: Challenges, disappointments, and opportunities", Adv. Drug Deliv. Rev. 17, 117-127.
85. Nagy, J.A., Brown, L.F., Senger, D.R., Lanir, N., Van de Water, L., Dvorak, A.M. and Dvorak, H.F. (1989) "Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition", Biochim. Biophys. Acta 948, 305-326.
86. Netti, P.A., Berk, D.A., Swartz, M.A., Grodzinsky, A.J. and Jain, R.K. (2000) "Role of extracellular matrix assembly in interstitial transport in solid tumors", Cancer Res. 60, 2497-2503.
87. Nishi, T., Yoshizato, K., Yamashiro, S., Takeshima, H., Sato, K., Hamada, K., Kitamura, I., Yoshimura, T., Saya, H., Kuratsu, J. and Ushio, Y. (1996) "High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation", Cancer Res. 56, 1050-1055.
88. Ohizumi, I., Tsunoda, S., Taniguchi, K., Saito, H., Esaki, K., Makimoto, H., Wakai, Y., Tsutsumi, Y., Nakagawa, S., Utoguchi, N., Kaiho, S., Ohsugi, Y. and Mayumi, T. (1997) "Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats", Biochem. Biophys. Res. Commun. 236, 492-496.
89. O'Reilly, M.S., Holmgren, L., Chen, C. and Folkman, J. (1996) "Angiostatin induces and sustains dormancy of human primary tumors in mice", Nat. Med. 2, 689-692.
90. Paget, S. (1889) "The distribution of secondary growths in cancer of the breast", Lancet 1, 571-573.
91. Patan, S., Munn, L.L. and Jain, R.K. (1996) "Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: A novel mechanism of tumor angiogenesis", Microvasc. Res. 51, 260-272.
92. Pavco, P.A., Bouhana, K.S., Gallegos, A.M., Agrawal, A., Blanchard, K.S., Grimm, S.L., Jensen, K.L., Andrews, L.E., Wincott, F.E., Pitot, P.A., Tressler, R.J., Cushman, C., Reynolds, M.A. and Parry, T.J. (2000) "Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors", Clin. Cancer Res. 6, 2094-2103.
93. Peichev, M., Naiyer, A.J., Pereira, D., Zhu, Z., Lane, W.J., Williams, M., Oz, M.C., Hicklin, D.J., Witte, L., Moore, M.A. and Rafii, S. (2000) "Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors", Blood 95, 952-958.
94. Pepper, M.S. (1997) "Manipulating angiogenesis: From basic science to the bedside", Arterioscler Thromb. Vasc. Biol. 17, 605-619.
95. Presta, L.G., Chen, H., O'Connor, S.J., Chisholm, V., Meng, Y.G., Krummen, L., Winkler, M. and Ferrara, N. (1997) "Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders", Cancer Res. 57, 4593-4599.
96. Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., Hooper, A., Pytowski, B., Witte, L., Bohlen, P. and Hicklin, D.J. (1999) "Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors", Cancer Res. 59, 5209-5218.
97. Rainov, N.G., Ikeda, K., Qureshi, N.H., Grover, S., Herrlinger, U., Pechan, P., Chiocca, E.A., Breakefield, X.O. and Barnett, F.H. (1999) "Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms", Hum. Gene Ther. 10, 311-318.
98. Risau, W. (1997) "Mechanisms of angiogenesis", Nature 386, 671-674.
99. Risau, W. and Flamme, I. (1995) "Vasculogenesis", Annu. Rev. Cell Dev. Biol. 11, 73-91.
100. Ruoslahti, E. (1999) "Fibronectin and its integrin receptors in cancer", Adv. Cancer Res. 76, 1-20.
101. Ruoslahti, E. and Reed, J.C. (1994) "Anchorage dependence, integrins, and apoptosis", Cell 77, 477-478.
102. Saaristo, A., Karpanen, T. and Alitalo, K. (2000) "Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis", Oncogene 19, 6122-6129.
103. Satchi-Fainaro, R., Puder, M., Davies, J.W., Tran, H.T., Sampson, D.A., Greene, A.K., Corfas, G. and Folkman, J. (2004) "Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470", Nat. Med. 10, 255-261.
104. Schietroma, C., Cianfarani, F., Lacal, P.M., Odorisio, T., Orecchia, A., Kanitakis, J., D'Atri, S., Failla, C.M. and Zambruno, G. (2003) "Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases", Cancer 98, 789-797.
105. Schmid, R.M., Weidenbach, H., Yamagushi, H., Luhrs, H., Liptay, S. and Adler, G. (1998) "Direct gene transfer into the rat pancreas using DNA-liposomes", Eur. J. Clin. Investig. 28, 220-226.
106. Semple, S.C., Klimuk, S.K., Harasym, T.O., Dos Santos, N., Ansell, S.M., Wong, K.F., Maurer, N., Stark, H., Cullis, P.R., Hope, M.J. and Scherrer, P. (2001) "Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures", Biochim. Biophys. Acta 1510, 152-166.
107. Senger, D.R. (1996) "Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines", Am. J. Pathol. 149, 1-7.
108. Sevick, E.M. and Jain, R.K. (1991) "Effect of red blood cell rigidity on tumor blood flow: Increase in viscous resistance during hyperglycemia", Cancer Res. 51, 2727-2730.
109. Shi, W. and Siemann, D.W. (2002) "Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor", Br. J. Cancer 87, 119-126.
110. Singh, R.K., Bucana, C.D., Gutman, M., Fan, D., Wilson, M.R. and Fidler, I.J. (1994) "Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells", Am. J. Pathol. 145, 365-374.
111. Sokoloff, M.H. and Chung, L.W.K. (1999) "Targeting angiogenic pathways involving tumour-stromal interaction to treat advanced human prostate cancer", Cancer Metastasis Rev. 17, 307-315.
112. Stearne, L.E., Schifferlers, R.M., Smouter, E., Bakker-Woudenberg, I.A. and Gussens, I.C. (2002) "Biodistribution of long-circulating PEG-liposomes in a murine model of established subcutaneous abscesses", Biochim. Biophys. Acta 1561, 91-97.
113. Su, J.L., Shih, J.Y, Yen, M.L., Jeng, Y.M., Chang, C.C., Hsieh, C.Y, Wei, L.H., Yang, P.C. and Kuo, M.L. (2004) " Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: A novel mechanism of lymph angiogenesis in lung adenocarcinoma", Cancer Res. 64, 554-564.
114. Takahashi, Y., Mai, M., Wilson, M.R. and Ellis, L.M. (1996) "Site-dependent expression of vascular endothelial growth factor, angiogenesis and proliferation in human gastric carcinoma", Int. J. Oncol. 8, 701-705.
115. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J.M. and Asahara, T. (1999) " Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization", Nat. Med. 5, 434-438.
116. Thorpe, P.E. (2004) "Vascular targeting agents as cancer therapeutics", Clin. Cancer Res. 10, 415-427.
117. Thurston, G., McLean, J.W., Rizen, M., Baluk, P., Haskell, A., Murphy, T.J., Hanahan, D. and McDonald, D.M. (1998) "Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice", J. Clin. Investig. 101, 1401-1413.
118. Veenendaal, L.M., Jin, H., Ran, S., Cheung, L., Navone, N., Marks, J.W., Waltenberger, J., Thorpe, P. and Rosenblum, M.G. (2002) "In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors", Proc. Natl Acad. Sci. USA 99, 7866-7871.
119. Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) "Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma", N. Eng. J. Med. 324, 1-8.
120. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E.N., Moore, D.H., Meli, S. and Gasparini, G. (1992) "Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma", J. Natl Cancer Inst. 84, 1875-1887.
121. Weinbaum, S., Cowin, S.C. and Zeng, Y. (1994) "A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses", J. Biomech. 27, 339-360.
122. Yamada, S., Melder, R.J., Leunig, M., Ohkubo, C. and Jain, R.K. (1995) "Leukocyte rolling increases with age", Blood 86, 4707-4708.
123. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H. and Kuwano, M. (1997) "Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor-α-dependent angiogenesis", Mol. Cell Biochem. 17, 4015-4023.
124. Yuan, F., Salehi, H.A., Boucher, Y., Vasthare, U.S., Tuma, R.F. and Jain, R.K. (1994) "Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows", Cancer Res. 54, 4564-4568.
125. Zhao, Q., Song, X., Waldschmidt, T., Fisher, E. and Krieg, A.M. (1996) "Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation", Blood 88, 1788-1795.